Literature DB >> 6793126

Paget's disease of bone.

D J Hosking.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6793126      PMCID： PMC1507001          DOI： 10.1136/bmj.283.6293.686

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  23 in total

1.  Osteoclast ultrastructure in Paget's disease.

Authors:  A Rebel; K Malkani; M Baslé; C Bregeon
Journal:  Calcif Tissue Res       Date:  1976-04-20

2.  Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.

Authors:  A Avramides; A Flores; J DeRose; S Wallach
Journal:  J Clin Endocrinol Metab       Date:  1976-03       Impact factor: 5.958

3.  Subacute sclerosing panencephalitis virus. Observations on a neuroadapted and non-neuroadapted strain in organotypic central nervous system cultures.

Authors:  C S Raine; L A Feldman; R D Sheppard; L H Barbosa; M B Bornstein
Journal:  Lab Invest       Date:  1974-07       Impact factor: 5.662

Review 4.  The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover.

Authors:  A M Parfitt
Journal:  Metabolism       Date:  1976-07       Impact factor: 8.694

5.  Nuclear inclusions in Paget's disease of bone.

Authors:  B G Mills; F R Singer
Journal:  Science       Date:  1976-10-08       Impact factor: 47.728

6.  Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.

Authors:  J G Haddad; J G Caldwell
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

7.  An evaluation of antibodies and clinical resistance to salmon calcitonin.

Authors:  F R Singer; J P Aldred; R M Neer; S M Krane; J T Potts; K J Bloch
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

8.  Paget's bone disease treated with diphosphonate and calcitonin.

Authors:  D J Hosking; O L Bijvoet; J van Aken; E J Will
Journal:  Lancet       Date:  1976-03-20       Impact factor: 79.321

9.  Diphosphonate therapy of paget's disease of bone.

Authors:  R Canfield; W Rosner; J Skinner; J McWhorter; L Resnick; F Feldman; S Kammerman; K Ryan; M Kunigonis; W Bohne
Journal:  J Clin Endocrinol Metab       Date:  1977-01       Impact factor: 5.958

10.  Treatment of Paget's disease of bone with synthetic salmon calcitonin.

Authors:  J A Kanis; D B Horn; R D Scott; J A Strong
Journal:  Br Med J       Date:  1974-09-21
View more
  11 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 2.  Paget disease of bone.

Authors:  G David Roodman; Jolene J Windle
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  Guidelines for diagnosis and management of Paget's disease of bone in Japan.

Authors:  Shinjiro Takata; Jun Hashimoto; Kiyoshi Nakatsuka; Noriko Yoshimura; Kousei Yoh; Ikko Ohno; Hiroo Yabe; Satoshi Abe; Masao Fukunaga; Masaki Terada; Masaaki Zamma; Stuart H Ralston; Hirotoshi Morii; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

4.  Silent swelling of the tibia in a 43-year-old man.

Authors:  Ali Ocguder; Osman Tecimel; Ahmet Firat; Murat Bozkurt
Journal:  Clin Orthop Relat Res       Date:  2008-02-14       Impact factor: 4.176

5.  Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.

Authors:  Jumpei Teramachi; Hua Zhou; Mark A Subler; Yukiko Kitagawa; Deborah L Galson; David W Dempster; Jolene J Windle; Noriyoshi Kurihara; G David Roodman
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

6.  Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.

Authors:  N Kurihara; S V Reddy; C Menaa; D Anderson; G D Roodman
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 7.  Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene.

Authors:  Giacomina Brunetti; Flaviana Marzano; Silvia Colucci; Annamaria Ventura; Luciano Cavallo; Maria Grano; Maria Felicia Faienza
Journal:  Endocrine       Date:  2012-05-26       Impact factor: 3.633

8.  Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.

Authors:  C Menaa; S V Reddy; N Kurihara; H Maeda; D Anderson; T Cundy; J Cornish; F R Singer; J M Bruder; G D Roodman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

9.  A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.

Authors:  Yuko Hiruma; Noriyoshi Kurihara; Mark A Subler; Hua Zhou; Christina S Boykin; Heju Zhang; Seiichi Ishizuka; David W Dempster; G David Roodman; Jolene J Windle
Journal:  Hum Mol Genet       Date:  2008-09-02       Impact factor: 6.150

Review 10.  An Insight in to Paget's Disease of Bone.

Authors:  Robin Sabharwal; Shivangi Gupta; Shipra Sepolia; Rajat Panigrahi; Saumyakanta Mohanty; Santosh Kumar Subudhi; Manish Kumar
Journal:  Niger J Surg       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.